ETFs Holding ABEO »    ABEO Historical Stock Prices »
ABEO News Video: Thu, Jun 22, 2017, 1:28 PM — Thursday Sector Leaders: Hospital & Medical Practitioners, Biotechnology Stocks

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Abeona Therapeutics is focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening diseases. Co.'s primary programs are ABO-101 and ABO-102, adeno-associated virus-based gene therapies for Sanfilippo syndrome. Co. is also developing ABO-201 gene therapy for Juvenile Neuronal Ceroid Lipofuscinoses also known as juvenile Batten disease; and ABO-301 for Fanconi anemia disorder using a CRISPR/Cas9-based gene editing approach to gene therapy program for blood diseases. In addition, Co. is also developing plasma protein therapies including PTB-101 SDF Alpha™ (alpha-1 protease inhibitor) for inherited chronic obstructive pulmonary disease. Self directed investors in Abeona Therapeutics Inc will be interested in keeping up with all Abeona Therapeutics Inc news they can find, both ABEO news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on ABEO. At RediNews, we simplify this task by presenting both ABEO news releases originating from Abeona Therapeutics Inc itself, and ABEO news from a variety of media outlets. Visitors can browse this news online and through our ABEO RSS news feed.


ABEO News — Articles, Videos, & Press Releases

How The Pieces Add Up: PZI Targets $21
Friday, June 16, 2017, 9:13 AM — ETF Channel
Short Sellers Drawn To These Five Louis Bacon Holdings
Monday, June 12, 2017, 2:41 PM — Dividend Channel
Abeona Therapeutics Enters Oversold Territory (ABEO)
Monday, June 12, 2017, 11:56 AM — Dividend Channel
Short Sellers Drawn To These Five Louis Bacon Holdings
Thursday, May 25, 2017, 3:31 PM — Dividend Channel
Look Under The Hood: PZI Has 12% Upside
Monday, May 15, 2017, 10:36 AM — ETF Channel
Louis Bacon Vs. The Shorts: Five Surprising Holdings
Wednesday, May 10, 2017, 1:00 PM — Dividend Channel
Louis Bacon Vs. The Shorts: Five Surprising Holdings
Wednesday, April 26, 2017, 1:26 PM — Dividend Channel
Louis Bacon Vs. The Shorts: Five Surprising Holdings
Wednesday, April 26, 2017, 1:26 PM — Dividend Channel
Short Sellers Drawn To These Five Louis Bacon Holdings
Wednesday, April 12, 2017, 2:15 PM — Dividend Channel
Analysts Anticipate PZI To Hit $20
Thursday, April 6, 2017, 9:12 AM — ETF Channel
5 Louis Bacon Holdings Attracting Short Sellers
Monday, March 27, 2017, 1:48 PM — Dividend Channel
Short Sellers Drawn To These Five Louis Bacon Holdings
Friday, March 10, 2017, 1:21 PM — Dividend Channel
First Week of ABEO April 21st Options Trading
Wednesday, February 22, 2017, 11:40 AM — Stock Options Channel
Abeona Therapeutics (ABEO) Catches Eye: Stock Jumps 5.8%
Wednesday, February 15, 2017, 7:00 AM — Zacks
Is Abeona Therapeutics (ABEO) Stock a Solid Choice Right Now?
Monday, December 12, 2016, 8:25 AM — Zacks
Abeona Therapeutics Becomes Oversold (ABEO)
Thursday, December 8, 2016, 11:59 AM — Dividend Channel
Interesting ABEO Put And Call Options For June 2017
Monday, October 24, 2016, 11:34 AM — Stock Options Channel
Abeona Therapeutics (ABEO) Surges: Stock Rises 11.3%
Thursday, October 6, 2016, 6:25 AM — Zacks
Drug Stocks' Earnings to Watch on Aug 12: CXRX, PTI & ABEO
Thursday, August 11, 2016, 7:58 AM — Zacks
IWC's Holdings Imply 21% Gain Potential
Thursday, July 28, 2016, 7:54 AM — ETF Channel
UWM's Underlying Holdings Imply 11% Gain Potential
Tuesday, June 14, 2016, 7:40 AM — ETF Channel
Analysts Anticipate IWC To Hit $85
Friday, May 13, 2016, 7:40 AM — ETF Channel
The Math Shows RSCO Can Go To $86
Tuesday, April 12, 2016, 7:46 AM — ETF Channel
Abeona Therapeutics (ABEO) Jumps: Stock Rises 6.4%
Tuesday, April 5, 2016, 6:40 AM — Zacks
Add Up The Pieces: RSCO Could Be Worth $86
Wednesday, March 9, 2016, 7:20 AM — ETF Channel
Why You Shouldn't Bet Against Abeona Therapeutics (ABEO) Stock
Monday, December 14, 2015, 7:30 AM — Zacks
ABEO: Insiders vs. Shorts
Tuesday, November 17, 2015, 2:24 PM — Market News Video
What's in Store for Voxeljet (VJET) This Earnings Season?
Monday, November 9, 2015, 10:20 AM — Zacks
Is Humana (HUM) Poised to Beat Q3 Earnings Estimates?
Wednesday, November 4, 2015, 1:50 PM — Zacks
Commit To Buy Abeona Therapeutics At $2.50, Earn 4.9% Annualized Using Options
Wednesday, October 21, 2015, 11:51 AM — Stock Options Channel
Commit To Purchase Abeona Therapeutics At $5, Earn 34.8% Annualized Using Options
Friday, July 10, 2015, 11:40 AM — Stock Options Channel
Abeona Therapeutics is Now Oversold (ABEO)
Monday, June 29, 2015, 4:48 PM — Dividend Channel
ABEO is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

ZBH News

RediNews invites those seeking web page financial content for any internet portal, especially any vertical portal specializing in the markets where there is a web page for business, web page for markets, web page finance, etc., to integrate our free web site content, our RSS news feeds. These RSS feeds are found throughout our website wherever news and custom stock content is found, by clicking the RSS icon for any news page (which will look like this): . This dynamic financial content is ideal for sites that already feature stock data content such as historical stock price information whether in the form of a historical stock price table or a web page chart image, to supplement the other custom stock market content displayed.

ABEO News | | Copyright © 2013 - 2017, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.